BioTechne Corp (TECH)
(Real Time Quote from BATS)
$62.12 USD
-1.40 (-2.20%)
Updated Apr 25, 2024 10:46 AM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for BioTechne Corp falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 285.44 | 263.10 | 139.59 | 229.30 | 96.07 |
Depreciation/Amortization & Depletion | 107.24 | 101.07 | 87.75 | 82.74 | 78.17 |
Net Change from Assets/Liabilities | -90.58 | -69.52 | 29.26 | -5.25 | -27.75 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -47.71 | 30.62 | 95.57 | -101.57 | 35.13 |
Net Cash From Operating Activities | 254.39 | 325.27 | 352.16 | 205.22 | 181.62 |
Property & Equipment | -38.24 | -44.91 | -44.30 | -51.74 | -25.41 |
Acquisition/ Disposition of Subsidiaries | -101.18 | 0.00 | -225.35 | 0.00 | -289.49 |
Investments | -126.22 | -51.94 | 26.14 | 78.84 | -21.90 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -265.65 | -96.85 | -243.52 | 27.10 | -336.80 |
Uses of Funds
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 10.25 | -83.80 | 21.91 | 20.87 | 22.55 |
Issuance (Repayment) of Debt | -525.66 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 619.66 | -85.50 | -15.50 | -148.50 | 166.50 |
Payment of Dividends & Other Distributions | -50.29 | -50.19 | -49.62 | -48.90 | -48.36 |
Other Financing Activities | -31.35 | -23.37 | -19.34 | -7.27 | -6.30 |
Net Cash from Financing Activities | 22.62 | -242.85 | -62.55 | -183.80 | 134.38 |
Effect of Exchange Rate Changes | -3.36 | -12.09 | 6.37 | -2.77 | -0.31 |
Net Change In Cash & Equivalents | 8.00 | -26.52 | 52.47 | 45.74 | -21.10 |
Cash at Beginning of Period | 172.57 | 199.09 | 146.63 | 100.89 | 121.99 |
Cash at End of Period | 180.57 | 172.57 | 199.09 | 146.63 | 100.89 |
Diluted Net EPS | 1.76 | 1.66 | 0.87 | 1.46 | 0.62 |
Fiscal Year End for BioTechne Corp falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 78.46 | 50.99 | 285.44 | 209.96 |
Depreciation/Amortization & Depletion | NA | 56.34 | 28.54 | 107.24 | 80.32 |
Net Change from Assets/Liabilities | NA | -1.20 | -19.98 | -90.58 | -79.71 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 8.90 | -0.17 | -47.71 | -39.57 |
Net Cash From Operating Activities | NA | 142.50 | 59.38 | 254.39 | 171.00 |
Property & Equipment | NA | -28.46 | -13.59 | -38.24 | -27.41 |
Acquisition/ Disposition of Subsidiaries | NA | -169.71 | -166.43 | -101.18 | -101.18 |
Investments | NA | 18.23 | 23.76 | -126.22 | -132.30 |
Other Investing Activities | NA | 2.15 | 2.15 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -177.78 | -154.11 | -265.65 | -260.89 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -60.37 | 14.39 | 10.25 | 1.84 |
Issuance (Repayment) of Debt | NA | -128.00 | -70.00 | -525.66 | -505.66 |
Increase (Decrease) Short-Term Debt | NA | 225.00 | 160.00 | 619.66 | 619.66 |
Payment of Dividends & Other Distributions | NA | -25.21 | -12.65 | -50.29 | -37.69 |
Other Financing Activities | NA | -21.30 | -20.23 | -31.35 | -31.31 |
Net Cash from Financing Activities | NA | -9.89 | 71.51 | 22.62 | 46.84 |
Effect of Exchange Rate Changes | NA | -5.27 | -8.69 | -3.36 | -2.23 |
Net Change In Cash & Equivalents | NA | -50.44 | -31.91 | 8.00 | -45.29 |
Cash at Beginning of Period | NA | 180.57 | 180.57 | 172.57 | 172.57 |
Cash at End of Period | NA | 130.13 | 148.66 | 180.57 | 127.28 |
Diluted Net EPS | NA | 0.17 | 0.31 | 0.47 | 0.43 |